Moderna received U.S. FDA approval for updated COVID-19 vaccine
On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
-
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics | Women's Health
High levels of particulate air pollution associated with increased breast cancer incidence
On Sept. 11, 2023, researchers at the National Institutes of Health (NIH) reported that living in an area…
-
Pfizer and BioNTech received U.S. FDA approval for 2023-2024 COVID-19 vaccine
On Sept. 11, 2023, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
-
White House announced $240 million in additional investment to accelerate new ways to prevent, detect, treat cancer
On Sept. 10, 2023, the White House announced $240 million in additional investment through the Advanced Research Projects…
-
European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…
-
The Markey Cancer Center became an NCI-designated Comprehensive Cancer Center
On Sept. 6, 2023, the Markey Cancer Center (MCC) became Kentucky’s first and only National Cancer Institute (NCI)-Designated…
-
USDA broke ground on new Plant Research Facility on North Carolina State University campus
On Sept. 6, 2023, the U.S. Department of Agriculture’s Agricultural Research Service and NC State University’s College of…
-
OHSU achieved national milestone in new knee repair technique
On Sept. 6, 2023, Oregon Health & Science University (OHSU) announced it had achieved a landmark in orthopaedic…
-
Moderna clinical trial data confirmed updated Covid-19 vaccine generated strong immune response against BA.2.86 variant
On Sept. 6, 2023, Moderna announced that clinical trial data from its research assay confirmed its updated COVID-19…
-
Biotechnology | Disease | NIH
NIH investigated multidrug-resistant bacterium emerging in community settings
On Sept. 6, 2023, the National Institutes of Health (NIH) announced it was investgating ‘hypervirulent’ strains of the…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA Cleared 23andMe improved BRCA report for communities underrepresented in genetic testing
On Aug. 31, 2023, 23andMe, a leading human genetics and biopharmaceutical company, today announced the Company has received…
-
Results from single-dose psilocybin randomized clinical trial treatment for major depressive disorder published in JAMA
On Aug. 31, 2023, study results published in JAMA found that psilocybin treatment was associated with a clinically…
-
CDC awarded $279 million to 49 States, DC, and 40 local health departments to help prevent drug overdoses
On Aug. 31, 2023, the U.S. Centers for Disease Control and Prevention (CDC) awarded $279 million to 49…
-
COVID-19 | FDA | Infectious Disease | Vaccine
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
-
Emergents’ NARCAN Nasal Spray launched OTC making it possible for everyone to help save a life from an opioid overdose Emergency
On Aug. 30, 2023, Emergent BioSolutions announced NARCAN® Naloxone HCl Nasal Spray 4 mg will be available on shelves…
-
WHO initiative signed new licensing agreements on COVID-19 technologies
On Aug. 29, 2023, the COVID-19 Technology Access Pool (C-TAP), a multi-stakeholder partnership to facilitate sharing of intellectual…
-
CTE identified in brain donations from young amateur athletes
On Aug. 28, 2023, in a study of 152 deceased athletes less than 30 years old who were…
-
MIT and two California universities received $50 million grant for Army research
On Aug. 27, 2003, The Institute for Collaborative Biotechnologies (ICB) announced it was funding a $50 million five…
-
Eye cell atlas pinpoints where disease-causing genes are expressed, raising hope for inroads against blindness
On Aug. 25, 2023, Harvard’s Center for Brain Science announced the creation of an eye atlas that pinpoints…
-
CDC’s ACIP announced vaccines recommendation for 2023-24 seasonal influenza
On Aug. 25. 2023, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP)…
-
NIAID-funded study traced evolution of Malaria drug resistance in East Africa
On Aug. 24, 2023, the National Institute of Allergy and Infectious Diseases (NIAID) reported that emerging resistance to…
-
City of Hope received $32 million grant to advance novel therapies
On Aug. 24, 2023, researchers at City of Hope announced were awarded $32.3 million from the California Institute…
-
U.S. FDA approved first biosimilar to treat Multiple Sclerosis
On Aug. 24, 2023, the U.S. Food and Drug Administration (FDA) approved Sandoz’s Tyruko (natalizumab-sztn), the first biosimilar…
-
CDC reported risk assessment summary for SARS CoV-2 sublineage BA.2.86
On Aug. 23, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced 9 BA.2.86 variant sequences…
-
Scientists released the first complete sequence of a human Y chromosome
On Aug. 23. 2023, researchers co-led by University of California, Santa Cruz Assistant Professor of Biomolecular Engineering Karen…
-
Parkinson’s disease gene variant found in study of some people of African ancestry
On Aug. 23, 2023, a gene variant found almost exclusively in the genomes of people of African ancestry…
-
Aspirin can help prevent a second heart attack, but most don’t take it
On Aug. 22, 2023, a study led by researchers at Washington University School of Medicine in St. Louis…
-
Alberta Innovates invested $13.6 million to strengthen Alberta’s technology sector
On Aug. 22, 2023, Alberta Innovates announced that more than $13.6 million will go to 19 partners, across…
-
Project NextGen awarded over $1.4 billion to develop future of COVID-19 vaccines and therapeutics
On Aug. 22, 2023, the U.S. Department of Health and Human Services (HHS) announced it had awarded more…
-
U.S. FDA approved ABRYSVO, Pfizer’s vaccine for prevention of RSV in infants through active immunization of pregnant Individuals
On Aug. 21, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO (Respiratory…
![European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older](https://lifesciencehistory.com/wp-content/uploads/2022/08/european_commission_logo-768x768.jpg){kind=logo}
